CTMX Latest Press Releases

-- September 1, 2026 --

CytomX Therapeutics to Present at Upcoming September Investor Conferences Globe Newswire 8:00 AM

-- August 27, 2026 --

CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan ('Varseta-M') for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC) Globe Newswire 8:00 AM

-- August 6, 2026 --

CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update Globe Newswire 4:15 PM

-- August 3, 2026 --

CytomX Therapeutics Appoints Alejandra Carvajal as Chief Legal Officer Globe Newswire 8:00 AM

-- July 30, 2026 --

CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026 Globe Newswire 8:00 AM

-- July 27, 2026 --

CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors Globe Newswire 8:00 AM

-- July 6, 2026 --

A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs PRNewswire 11:20 AM

-- June 3, 2026 --

CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes